MarketResearch.com logo

Recent Multiple Sclerosis (MS) Research for October 2021


Autoimmune Disease Drug Market Research Report by Indication (Diabetes Mellitus Type 1, Multiple Sclerosis, and Rare Diseases), by Drug Class (Anti-inflammatory, Antihyperglycemic, and Immunosuppressants), by Distribution, by Region (Americas, Asia-Pacifi
Topics: Diabetes, Autoimmune, Multiple Sclerosis (MS), COVID-19/Coronavirus
Regions: Asia, Europe, Middle East, Oceania, Global
Multiple Sclerosis Therapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
Topics: Multiple Sclerosis (MS)
Regions: Global
Central Nervous System Disorders Therapeutics Market, by Disease Type (Neurovascular Diseases, Trauma, Mental Health {Anxiety Disorders, Epilepsy, and Others}, Degenerative Diseases {Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, and Others
Topics: Alzheimer's Disease, Mental Health, Parkinson's Disease, Multiple Sclerosis (MS), Epilepsy, Hospitals & Clinics, Drug Discovery, CNS/Neurology
Regions: Asia, Middle East, North America, Oceania
Global Multiple Sclerosis Therapeutics Market Growth (Status and Outlook) 2021-2026
Topics: Multiple Sclerosis (MS), Drug Discovery
Regions: Global
Multiple Sclerosis - Global Clinical Trials Review, H2, 2021
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
Global Multiple Sclerosis Therapies Market Growth (Status and Outlook) 2021-2026
Topics: Multiple Sclerosis (MS)
Regions: Global
Global Central Nervous System Therapeutics Market, By Drug Class (Multiple Sclerosis, Antipsychotic, Antiepileptics, Analgesics & Anesthetics, Anti-Parkinson, Others), By Application (Neurodegenerative Diseases, Mental Health and Trauma, Neurovascular Dis
Topics: Cancer Treatment, Mental Health, Parkinson's Disease, Multiple Sclerosis (MS), Hospitals & Clinics, Pharmacy & Distribution, Drug Discovery, Clinical Nutrition, Drug Stores, Infectious Diseases, CNS/Neurology
Regions: Global
Global Multiple Sclerosis Therapies Market 2021 by Company, Regions, Type and Application, Forecast to 2026
Topics: Multiple Sclerosis (MS)
Regions: Global
Neurological Biomarkers Market, by Biomarker Type (Imaging Biomarkers, Metabolomics Biomarkers, Proteomic Biomarkers, and Genomics Biomarkers), by Application (Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Autism Spectrum Disorders, and Ot
Topics: Genomics, Proteomics, Biomarkers, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis (MS), Hospitals & Clinics, CNS/Neurology
Regions: Asia, Europe, Middle East, North America, Oceania
Microbiome Global Market Report 2021: COVID 19 Growth And Change to 2030Including: 1) By Type: Fecal Microbiota Transplantation (FMT); Microbiome drugs2) By Application: Inflammatory Bowel Disease; Diabetes; Multiple Sclerosis; Rheumatoid Arthritis; Other
Topics: Genomics, Proteomics, Genetic Engineering, Arthritis, Diabetes, Multiple Sclerosis (MS), COVID-19/Coronavirus, Blood Supply, Tissue Banking, Transplantation, Diabetes, Drug Discovery, Rheumatology/Arthritis
Regions: Global
Relapsing-remitting multiple sclerosis - Pipeline Insight, 2021
Topics: Multiple Sclerosis (MS), Drug Discovery
South and Central America Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class (Immunosuppressant and Immunomodulators), Route of Administration (Injectable and Oral), and Distribution Channel (Hosp
Topics: Multiple Sclerosis (MS), COVID-19/Coronavirus, Hospitals & Clinics, Needles, Syringes, IV Access, Pharmacy & Distribution, Drug Discovery, Drug Stores
Regions: Central America
Global Multiple Sclerosis Treatment Market Research Report 2021-2025
Topics: Multiple Sclerosis (MS)
Regions: Global
Global Relapsing Multiple Sclerosis Treatment Market Growth (Status and Outlook) 2021-2026
Topics: Multiple Sclerosis (MS)
Regions: Global
Global Multiple Sclerosis Therapeutics Market Research Report 2021-2025
Topics: Multiple Sclerosis (MS), Drug Discovery
Regions: Global
An Anti-Inflammatory Therapeutics Market by Drug Class (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, and Biologics), Indication Type (Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis
Topics: Biologics, Arthritis, Multiple Sclerosis (MS), Psoriasis, Drug Discovery, Biopharmaceuticals, Respiratory/Pulmonary
Regions: Global
Residue Testing Market Research Report by Residue Type (Allergens, Heavy Metals, Pesticides, and Toxins), by Detection Techniques (HPLC, Immunoassay-based, and LC-MS/MS), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19
Topics: Pesticides, Multiple Sclerosis (MS), COVID-19/Coronavirus, Regulation, Food Safety, Immunoassays
Regions: Global
Specialty Drug Distribution Market Research Report by Indication (AIDS, Hemophilia, Multiple Sclerosis, Oncology, and Rheumatoid Arthritis), by Type (Full line Wholesalers and Specialty Distributors), by Distribution Type, by Distribution Channel - Global
Topics: Wholesaling, AIDS, HIV & STDs, Arthritis, Blood Diseases, Multiple Sclerosis (MS), COVID-19/Coronavirus, Pharmacy & Distribution, Oncology/Hematology, Rheumatology/Arthritis
Regions: Global
Asia Pacific Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class (Immunosuppressant and Immunomodulators), Route of Administration (Injectable and Oral), and Distribution Channel (Hospital Pharmaci
Topics: Multiple Sclerosis (MS), COVID-19/Coronavirus, Hospitals & Clinics, Needles, Syringes, IV Access, Pharmacy & Distribution, Drug Discovery, Drug Stores
Regions: Asia, Oceania
Europe Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class (Immunosuppressant and Immunomodulators), Route of Administration (Injectable and Oral), and Distribution Channel (Hospital Pharmacies, Re
Topics: Multiple Sclerosis (MS), COVID-19/Coronavirus, Hospitals & Clinics, Needles, Syringes, IV Access, Pharmacy & Distribution, Drug Discovery, Drug Stores
Regions: Europe
Middle East and Africa Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class (Immunosuppressant and Immunomodulators), Route of Administration (Injectable and Oral), and Distribution Channel (Hospita
Topics: Multiple Sclerosis (MS), COVID-19/Coronavirus, Hospitals & Clinics, Needles, Syringes, IV Access, Pharmacy & Distribution, Drug Discovery, Drug Stores
Regions: Middle East
North America Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class (Immunosuppressant and Immunomodulators), Route of Administration (Injectable and Oral), and Distribution Channel (Hospital Pharmac
Topics: Multiple Sclerosis (MS), COVID-19/Coronavirus, Hospitals & Clinics, Needles, Syringes, IV Access, Drug Discovery, Drug Stores
Regions: North America
Interferons Global Market Report 2021: COVID 19 Implications And Growth to 2030
Topics: Research & Development, Drug Development, Hepatitis, Multiple Sclerosis (MS), COVID-19/Coronavirus
Regions: Global
Global Multiple Sclerosis Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
Topics: Multiple Sclerosis (MS)
Regions: Global
Multiple Sclerosis Market Research Report by Treatment Modality (Injectable Agents and Oral Agents), by Application (Hospital and Research) - United States Forecast to 2025 - Cumulative Impact of COVID-19
Topics: Multiple Sclerosis (MS), COVID-19/Coronavirus, Hospitals & Clinics
Regions: United States
Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Class (Immunosuppressant and Immunomodulators), Route of Administration (Injectable and Oral), and Distribution Channel (Hospital Pharmacies, Retail Phar
Topics: Multiple Sclerosis (MS), COVID-19/Coronavirus, Hospitals & Clinics, Pharmacy & Distribution, Drug Discovery, Drug Stores
Regions: Global
Multiple Sclerosis Therapeutics
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
Regions: Global
Digital Health in Neurology - Thematic Research
Topics: Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis (MS), Telemedicine, EMR (Electronic Medical Record), CNS/Neurology
Neuroprotection Market Research Report by Product (Apoptosis Inhibitors, Free Anti-Inflammatory Agents, Glutamate Antagonists, Metal Ion Chelators, and Neurotrophic Factors), by Treatment (Alzheimer's disease, Amyotrophic lateral sclerosis, Brain injury,
Topics: Stem Cell, Alzheimer's Disease, Huntington's, Multiple Sclerosis (MS), COVID-19/Coronavirus, CNS/Neurology
Regions: Global
Multiple Sclerosis Therapeutics Market - Growth, Trends, and Forecast (2020 - 2025)
Topics: Multiple Sclerosis (MS), Drug Discovery
Neuroprotection Market Research Report by Product (Apoptosis Inhibitors, Free Anti-Inflammatory Agents, Glutamate Antagonists, Metal Ion Chelators, and Neurotrophic Factors), by Treatment (Alzheimer's disease, Amyotrophic lateral sclerosis, Brain injury,
Topics: Stem Cell, Alzheimer's Disease, Huntington's, Multiple Sclerosis (MS), COVID-19/Coronavirus, CNS/Neurology
Regions: United States
United States Specialty Pharmaceuticals Market & Forecast by Application (Oncology, Autoimmune, Immunology, HIV, Multiple Sclerosis, Hematology, AMD, HGH, Others), Companies
Topics: AIDS, HIV & STDs, Autoimmune, Multiple Sclerosis (MS), Manufacturing, Packaging & Detailing, Research & Development, Oncology/Hematology, Allergy/Immunology
Regions: United States
Global Multiple Sclerosis Therapeutics Market- 2020-2027
Topics: Multiple Sclerosis (MS), Drug Discovery
Regions: Global
Global Stem Cell Therapy for Multiple Sclerosis Market 2021 by Company, Regions, Type and Application, Forecast to 2026
Topics: Stem Cell, Multiple Sclerosis (MS)
Regions: Global
Multiple Sclerosis Disease - Global Clinical Trials Review, H1, 2021
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
Global Multiple Sclerosis Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025
Topics: Multiple Sclerosis (MS), Drug Discovery
Regions: Global
Global Autoinjectors Market By Type (Disposable Autoinjectors and Reusable Autoinjectors), By Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis and other Applications), By End Use (Hospitals & Clinics and Home care settings), By Region, I
Topics: Arthritis, Multiple Sclerosis (MS), Hospitals & Clinics, Needles, Syringes, IV Access, Drug Delivery, Rheumatology/Arthritis
Regions: Global
North America Autoinjectors Market By Type (Disposable autoinjectors and Reusable autoinjectors), By Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis and other Applications), By End Use (Hospitals & Clinics and Home care settings), By Co
Topics: Arthritis, Multiple Sclerosis (MS), Hospitals & Clinics, Needles, Syringes, IV Access, Drug Delivery, Rheumatology/Arthritis
Regions: North America
Europe Autoinjectors Market By Type (Disposable autoinjectors and Reusable autoinjectors), By Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis and other Applications), By End Use (Hospitals & Clinics and Home care settings), By Country,
Topics: Arthritis, Multiple Sclerosis (MS), Hospitals & Clinics, Needles, Syringes, IV Access, Drug Delivery, Rheumatology/Arthritis
Regions: Europe
Beta Interferon
Topics: Research & Development, Multiple Sclerosis (MS)
Regions: Global
Electronic Drug Delivery System Market Research Report by Type (Electronic Autoinjectors, Electronic Inhalers, Electronic Injection Pens, and Electronic Wearable Infusion Pumps), by Indication (Asthma & COPD, Cardiovascular Disease, Diabetes, and Multiple
Topics: Asthma, Diabetes, Heart Health, Multiple Sclerosis (MS), COVID-19/Coronavirus, Transdermal & Implantable, Infusion Products, Respiratory Devices, Drug Delivery Systems, Drug Delivery
Regions: Global
Autoimmune Disease Drug Market Research Report by Indication (Diabetes Mellitus Type 1, Multiple Sclerosis, Rare Diseases, and Rheumatic Diseases), by Drug Class (Anti-inflammatory, Antihyperglycemic, Immunosuppressants, Interferons, and NSAIDs), by Distr
Topics: Research & Development, Diabetes, Autoimmune, Multiple Sclerosis (MS), COVID-19/Coronavirus, Research & Development
Regions: Global
Specialty Drug Distribution Market Research Report by Indication (AIDS, Hemophilia, Multiple Sclerosis, Oncology, and Rheumatoid Arthritis), by Type (Full line Wholesalers and Specialty Distributors), by Distribution Type, by Distribution Channel - United
Topics: AIDS, HIV & STDs, Arthritis, Blood Diseases, Multiple Sclerosis (MS), COVID-19/Coronavirus, Manufacturing, Packaging & Detailing, Pharmacy & Distribution, Prescription Drugs, E-Commerce & Online Retailing
Regions: United States
Autoimmune Disease Drug Market Research Report by Indication (Diabetes Mellitus Type 1, Multiple Sclerosis, Rare Diseases, and Rheumatic Diseases), by Drug Class (Anti-inflammatory, Antihyperglycemic, Immunosuppressants, Interferons, and NSAIDs), by Distr
Topics: Research & Development, Autoimmune, Multiple Sclerosis (MS), COVID-19/Coronavirus
Regions: United States
Electronic Drug Delivery System Market Research Report by Type (Electronic Autoinjectors, Electronic Inhalers, Electronic Injection Pens, and Electronic Wearable Infusion Pumps), by Indication (Asthma & COPD, Cardiovascular Disease, Diabetes, and Multiple
Topics: Asthma, Diabetes, Multiple Sclerosis (MS), COVID-19/Coronavirus, Transdermal & Implantable, Diabetes, Infusion Products, Respiratory Devices, Drug Delivery Systems, Drug Delivery
Regions: United States
Multiple Sclerosis Market Research Report by Treatment Modality (Injectable Agents and Oral Agents), by Application (Hospital and Research) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Topics: Multiple Sclerosis (MS), COVID-19/Coronavirus, Hospitals & Clinics
Regions: Global
Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular Diseases, Diabetes), Type (Disposable, Reusable), Route of administration (Subcutaneous, Intramuscular), End User (Hospital) - Global Forecast to 2025
Topics: Arthritis, Diabetes, Multiple Sclerosis (MS), Hospitals & Clinics, Diabetes, Needles, Syringes, IV Access, Drug Delivery, Rheumatology/Arthritis
Regions: Global
Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2028
Topics: Multiple Sclerosis (MS)
Regions: Global
Multiple Sclerosis - Pipeline Review, H1 2020
Topics: Multiple Sclerosis (MS), Drug Discovery
Global Neurodegenerative Disorder Therapeutics Market: Focus on Product, Mechanism, Route of Administration, Indication, Country Data (14 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2030
Topics: Alzheimer's Disease, Parkinson's Disease, Huntington's, Multiple Sclerosis (MS), Drug Discovery, Clinical Trial, CNS/Neurology
Regions: Global


Prev  | 1  | 2  | 3  | Next    

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.